Cells from elite controllers are not intrinsically resistant to HIV infection, which suggests that virologic control in these patients may be due to antiviral immune responses.
A small proportion of HIV-infected patients can control viral replication without antiretroviral therapy (ART). Such patients are often divided into two groups: Typically, those who maintain undetectable viral loads (<50 copies/mL) are considered “elite controllers,” whereas those who maintain low but detectable viral loads (50–2000 copies/mL) are considered “viremic controllers.”
To understand the basis of HIV control, investigators performed an in-depth analysis of viral and immunologic characteristics among elite controllers, viremic controllers, and untreated progressors (those with viral loads >10,000 copies/mL). The main findings:
Reviewing Author
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)